28.23
price up icon4.67%   1.26
after-market Handel nachbörslich: 27.85 -0.38 -1.35%
loading

Mineralys Therapeutics Inc Aktie (MLYS) Neueste Nachrichten

pulisher
07:49 AM

Profit Recap: Is Mineralys Therapeutics Inc impacted by rising ratesQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn

07:49 AM
pulisher
12:22 PM

Why Mineralys Therapeutics Stock Is Surging Today - TipRanks

12:22 PM
pulisher
10:46 AM

Avalyn Appoints Biopharmaceutical Veteran to Board - National Today

10:46 AM
pulisher
10:13 AM

Avalyn Appoints Jon Congleton To Board - citybiz

10:13 AM
pulisher
08:11 AM

Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors - The Manila Times

08:11 AM
pulisher
Apr 05, 2026

Mineralys Therapeutics (MLYS) garnering attention with lorundrostat progress - MSN

Apr 05, 2026
pulisher
Apr 05, 2026

Earnings Miss: Whats the RSI of Mineralys Therapeutics Inc stock2026 Levels & Capital Protection Trading Alerts - baoquankhu1.vn

Apr 05, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock By Investing.com - Investing.com Australia

Apr 02, 2026
pulisher
Apr 02, 2026

Insider Sell: CEO Jon Congleton Sells 75,000 Shares of Mineralys Therapeutics Inc (MLYS) - GuruFocus

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) CEO Jon Congleton Sells 75,000 Shares - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells 3,000 Shares of Stock - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock By Investing.com - Investing.com Australia

Apr 02, 2026
pulisher
Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock - Investing.com

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys (MLYS) CEO sells 75,000 shares, still holds 705k - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics (MLYS) director trades 3,000 shares under plan - Stock Titan

Apr 02, 2026
pulisher
Apr 02, 2026

IPO Launch: How sensitive is Mineralys Therapeutics Inc to inflationMarket Rally & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Director Acquires $7,354,269.00 in Stock - MarketBeat

Apr 02, 2026
pulisher
Apr 02, 2026

Mineralys Therapeutics, Inc. (MLYS) stock price, news, quote and history - Yahoo Finance UK

Apr 02, 2026
pulisher
Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX) - The Globe and Mail

Apr 01, 2026
pulisher
Apr 01, 2026

Mineralys Therapeutics Surges on FDA Milestone Buzz - TipRanks

Apr 01, 2026
pulisher
Apr 01, 2026

Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Insider Monkey

Apr 01, 2026
pulisher
Apr 01, 2026

Mineralys Therapeutics(MLYS.US) Director Buys US$8.76 Million in Common Stock - 富途牛牛

Apr 01, 2026
pulisher
Mar 31, 2026

Mineralys Therapeutics (NASDAQ: MLYS) insider sells 3,000 shares - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Mineralys Therapeutics (MLYS) files Form 144 to sell 75,000 shares - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

RA Capital funds add 369,000 Mineralys (NASDAQ: MLYS) shares - Stock Titan

Mar 31, 2026
pulisher
Mar 31, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4%What's Next? - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Investors Purchase High Volume of Mineralys Therapeutics Put Options (NASDAQ:MLYS) - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Immunic appoints biopharmaceutical executive Jon Congleton to board - Yahoo! Finance Canada

Mar 31, 2026
pulisher
Mar 31, 2026

Ex-Copaxone launch executive joins Immunic board as MS trial nears - stocktitan.net

Mar 31, 2026
pulisher
Mar 31, 2026

(MLYS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Mar 31, 2026
pulisher
Mar 31, 2026

SG Americas Securities LLC Buys 130,758 Shares of Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Mar 31, 2026
pulisher
Mar 31, 2026

Major Insider Power Move Signals Growing Confidence in Mineralys Therapeutics - TipRanks

Mar 31, 2026
pulisher
Mar 27, 2026

Mineralys Therapeutics, Inc.Common Stock (NQ: MLYS - FinancialContent

Mar 27, 2026
pulisher
Mar 26, 2026

Mineralys reports 2025 results, advances hypertension drug review - MSN

Mar 26, 2026
pulisher
Mar 25, 2026

Mineralys Therapeutics names Jeffrey Munsie as chief legal officer By Investing.com - Investing.com Australia

Mar 25, 2026
pulisher
Mar 24, 2026

Biopharma Co. Gives New CLO $3.6 Million In Stock Awards - Law360

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics grants inducement equity awards to two new employees - msn.com

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics appoints Jeffrey Munsie as chief legal officer - TipRanks

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Grants Inducement Equity Awards to New Employee - MyChesCo

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics Appoints Jeffrey A. Munsie as Chief Legal Officer - citybiz

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics names Jeffrey Munsie as chief legal officer - Investing.com

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics appoints Jeffrey A. Munsie as chief legal officer - MarketScreener

Mar 24, 2026
pulisher
Mar 24, 2026

Mineralys Therapeutics Appoints Jeffrey A. Munsie As Chief Legal Officer - TradingView

Mar 24, 2026
pulisher
Mar 23, 2026

Mineralys Therapeutics (MLYS) Is Down 8.1% After Narrowed Loss, FDA Lorundrostat NDA AcceptanceWhat's Changed - simplywall.st

Mar 23, 2026
pulisher
Mar 22, 2026

Hudson Bay Capital Management LP Invests $2.87 Million in Mineralys Therapeutics, Inc. $MLYS - MarketBeat

Mar 22, 2026
pulisher
Mar 22, 2026

Earnings Beat: Whats the profit margin of Mineralys Therapeutics IncQuarterly Risk Review & Free Risk Controlled Daily Trade Plans - baoquankhu1.vn

Mar 22, 2026
pulisher
Mar 21, 2026

Growth Value: What is the implied volatility of Mineralys Therapeutics Inc2026 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn

Mar 21, 2026
pulisher
Mar 20, 2026

Is It Time To Reassess Mineralys Therapeutics (MLYS) After The Recent Share Price Pullback? - Yahoo Finance

Mar 20, 2026
pulisher
Mar 19, 2026

Mineralys (MLYS) Q4 2025 Earnings Call Transcript - AOL.com

Mar 19, 2026
pulisher
Mar 18, 2026

Why Mineralys Therapeutics Shares Are Sliding Today - TipRanks

Mar 18, 2026
pulisher
Mar 18, 2026

Research Analysts Issue Forecasts for MLYS Q1 Earnings - MarketBeat

Mar 18, 2026
$48.77
price down icon 0.87%
$27.88
price down icon 1.59%
$47.32
price down icon 2.57%
$91.28
price up icon 0.11%
ONC ONC
$302.49
price down icon 2.67%
$163.81
price up icon 0.85%
Kapitalisierung:     |  Volumen (24h):